Mark Hyman Rapaport
Department of Psychiatry
David Geffen School of Medicine at UCLA
Cedars-Sinai Medical Center
Los Angeles
USA
Name/email consistency: high
- Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia. Rapaport, M.H., Bresee, C. Neuropsychopharmacology (2010)
- Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial. Rapaport, M.H., Lydiard, R.B., Pitts, C.D., Schaefer, D., Bartolic, E.I., Iyengar, M., Carfagno, M., Lipschitz, A. J. Clin. Psychiatry (2009)
- Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. Rapaport, M.H. J. Clin. Psychiatry (2007)
- Translating the evidence on atypical depression into clinical practice. Hyman Rapaport, M. J. Clin. Psychiatry (2007)
- Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Rapaport, M.H., Gharabawi, G.M., Canuso, C.M., Mahmoud, R.A., Keller, M.B., Bossie, C.A., Turkoz, I., Lasser, R.A., Loescher, A., Bouhours, P., Dunbar, F., Nemeroff, C.B. Neuropsychopharmacology (2006)
- Quality-of-life impairment in depressive and anxiety disorders. Rapaport, M.H., Clary, C., Fayyad, R., Endicott, J. Am. J. Psychiatry (2005)
- Celecoxib augmentation of continuously ill patients with schizophrenia. Rapaport, M.H., Delrahim, K.K., Bresee, C.J., Maddux, R.E., Ahmadpour, O., Dolnak, D. Biol. Psychiatry (2005)
- Escitalopram continuation treatment prevents relapse of depressive episodes. Rapaport, M.H., Bose, A., Zheng, H. J. Clin. Psychiatry (2004)
- Efficacy of controlled-release paroxetine in the treatment of late-life depression. Rapaport, M.H., Schneider, L.S., Dunner, D.L., Davies, J.T., Pitts, C.D. J. Clin. Psychiatry (2003)
